NANO Nuclear Energy

Wedbush's initiation at Outperform with an $18 price target failed to hold NNE up, and the stock reversed from its intraday high to close about 4.2% lower at $10.95: it touched $11.85 at 09:31 ET, slid to $10.571 by 11:06 ET for a fresh 52-week low, then edged back to $11.00 after the bell. The position remains weak, down 60.34% year to date and 75.91% below the 52-week high of $45.46 set in November 2025, with the price under both the 20-day ($12.825) and 60-day ($15.927) averages. Fundamentals offer little cushion: Q3 2026 revenue was just $214,042 against a net loss of $10.10 million, 33% wider year over year, and EPS of -$0.193. Though the company signed an MOU with Hyundai Engineering for its Illinois KRONOS project and a three-year engineering agreement with IMPSA, keeping execution headlines flowing.

NNE closed up 4.5% at $11.45 after Wedbush initiated coverage at Outperform with an $18 price target, lifting the shares from a pre-market $10.85 just one session after a fresh 52-week low of $10.87. The regular session spiked to $11.76 at 09:46 ET before fading to $11.45, and post-market prints eased to $11.43. Company news flow also included an MOU with Hyundai Engineering for the Illinois KRONOS reactor and an engineering agreement with IMPSA. Fundamentals remain pre-revenue: Q3 2026 revenue was only $214,042, while net loss widened to $10.10 million and operating loss to $15.79 million versus the prior quarter, with EPS of -$0.193. The stock is down 58.5% year-to-date, 75.9% below its 52-week high of $47.58, and trades beneath its MA20 of $13.08 and MA60 of $16.07 at roughly 1.0x book. Though the $18 target sits well above the current price, a single session's bounce has not shifted a pattern still anchored near the 52-week low.

NNE closed up 4.05% at $12.34 after Nano Nuclear signed an MOU with Hyundai Engineering for the Illinois KRONOS reactor project, with the Korean builder having already committed $30 million to the reactor. The session traced a spike-and-fade: shares touched $11.86 pre-market at 04:07 ET, dipped to $12.10 at 09:32 ET, then jumped to an intraday high of $12.67 at 09:39 ET before giving back most of the gain and settling at $12.247 post-market at 16:08 ET. The bounce follows a fresh 52-week low and a 5.59% weekly decline, framing it as a low-level, news-driven recovery, with 1.55 million shares and $19.1 million traded in the regular session. Earlier milestones — a three-year engineering agreement with Argentina's IMPSA and KRONOS MMR advancing through NRC review with the University of Illinois — form a run of project progress, though one session has not moved the stock away from its 52-week low region.

NNE closed down about 6.0% in a spike-and-fade session: it reached 13.639 in pre-market at 04:01 ET, slid to an intraday low of 12.335 at 14:02 ET and settled at 12.525. The pre-market move followed a master services agreement and three-year engineering contract with Argentina's IMPSA covering critical KRONOS MMR components, but the momentum did not hold. Fundamentals remain loss-making: Q3 2026 operating loss of US$15.79 million worsened 75.65% year on year, net loss widened to US$10.10 million on revenue of only US$214,042, with market value near US$672.8 million, PB 1.09 and negative PE. The stock is down 54.62% year to date, 74.69% below the 52-week high of 49.5 and just 4.33% above the 12.01 low of Oct 15, and sits under MA20 of 14.735 and MA60 of 16.838. Though KRONOS MMR continues through NRC review with a 2027 build target.

NNE closed up 2.85% at $13.33 after signing a three-year master services agreement with Argentina's IMPSA for engineering and fabrication of critical KRONOS MMR components, lifting the stock from a $12.96 prior close to $13.41 in pre-market. The regular session spiked and faded: a 09:53 ET dip to $13.10 gave way to a $13.65 high at 14:10 ET before settling at $13.32, with 939k shares traded and 3.66% turnover. Fundamentals remain loss-making, with Q3 2026 revenue of $214k against a $10.1m net loss widening 33% yoy and EPS of -$0.193. Price positioning stays weak: down 51.72% YTD, 73.07% below the $49.50 52-week high of 2025-10-31, only 10.99% above the $12.01 low of 2026-10-15, and below both MA20 at 14.96 and MA60 at 16.88. Though NRC review and the targeted 2027 KRONOS build remain the swing factors.